Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

3.8K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.8K
COP Coated Vesicles00:59

COP Coated Vesicles

9.1K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
9.1K
Introduction to Membrane Traffic01:44

Introduction to Membrane Traffic

7.4K
The ER, Golgi apparatus, endosomes, and lysosomes work in tandem to modify, sort, and package proteins and lipids. An integrated membrane trafficking network facilitates the back and forth shuttling of molecules within different organelles in the same cell or across the cell membrane.
The transport of soluble and membrane proteins is mediated by transport vesicles that collect cargo from one cellular compartment and deliver it to another by fusing with the target organelle membrane. The Rab...
7.4K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

8.7K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.7K
Overview of Exosomes01:36

Overview of Exosomes

2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Exocytosis00:51

Exocytosis

68.5K
Exocytosis is used to release material from cells. Like other bulk transport mechanisms, exocytosis requires energy.
68.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?

Journal of medical virology·2026
Same author

How Strong Is the Link Between Merkel Cell Carcinoma and the Occurrence of Other Skin Cancer Types? A Meta-Analysis.

Experimental dermatology·2025
Same author

Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.

Cell death & disease·2025
Same author

Delivering therapeutic RNA into the brain using extracellular vesicles.

Molecular therapy. Nucleic acids·2024
Same author

Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.

Cell death & disease·2024
Same author

Merkel Cell Polyomavirus-Pathophysiology and Treatment in the Era of Gene-Targeted Therapies.

Reviews in medical virology·2024

Related Experiment Video

Updated: Sep 18, 2025

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

531

Extracellular Vesicle Lipids and Their Role in Delivery.

Austin Brent1,2, Paniz Shirmast1,2, Nigel A J McMillan1,2

  • 1Institute for Biomedicine and Glycomics Griffith University Queensland Australia.

Journal of Extracellular Biology
|June 24, 2025
PubMed
Summary

Small extracellular vesicles (sEVs) show promise as nanocarriers due to their biocompatibility. Their lipid profiles, not proteins, may drive these beneficial properties, suggesting potential for therapeutic applications.

Keywords:
EVEV‐mimeticexosomeexosome‐mimeticextracellular vesiclelipid compositionlipidomicssynEV

More Related Videos

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.0K
Membrane Remodeling of Giant Vesicles in Response to Localized Calcium Ion Gradients
08:15

Membrane Remodeling of Giant Vesicles in Response to Localized Calcium Ion Gradients

Published on: July 16, 2018

8.1K

Related Experiment Videos

Last Updated: Sep 18, 2025

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

531
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.0K
Membrane Remodeling of Giant Vesicles in Response to Localized Calcium Ion Gradients
08:15

Membrane Remodeling of Giant Vesicles in Response to Localized Calcium Ion Gradients

Published on: July 16, 2018

8.1K

Area of Science:

  • Biomedical Nanotechnology
  • Extracellular Vesicle Biology
  • Lipidomics

Background:

  • Small extracellular vesicles (sEVs) offer unique advantages as nanocarriers, including blood-brain barrier penetration and tissue tropism.
  • Clinical translation of sEVs is limited, with lipid nanoparticles (LNPs) still considered the benchmark for nanocarrier technology.
  • Emerging evidence suggests the lipid composition of sEVs significantly influences their therapeutic potential, more so than their proteome.

Purpose of the Study:

  • To review the current understanding of lipid profiles in sEVs from different cell sources.
  • To elucidate the functional roles of specific lipids in sEV-mediated biological activities.
  • To explore the potential of EV-mimetics and synthetic EVs (synEVs) for clinical applications.

Main Methods:

  • Literature review focusing on studies analyzing sEV lipid composition.
  • Analysis of research linking sEV lipid content to their function as nanocarriers.
  • Discussion of emerging EV-mimetic and synthetic EV (synEV) technologies.

Main Results:

  • Significant variation exists in the lipid composition of sEVs derived from different cell types.
  • Specific lipids within sEVs are increasingly recognized for their roles in mediating cellular interactions and therapeutic effects.
  • EV-mimetics and synEVs present promising avenues for overcoming current limitations in EV-based therapies.

Conclusions:

  • The lipidome of sEVs is a critical determinant of their efficacy as natural nanocarriers.
  • Further research into sEV lipid composition can unlock their full therapeutic potential.
  • Synthetic and mimetic approaches to EV technology may accelerate clinical translation and broaden therapeutic applications.